The Marburg Virus: The Story That Began in Germany — From 1967 to Today

August 1967. A quiet university city in West Germany. Laboratory workers handling African green monkeys begin to bleed — from their eyes, their gums, their noses. Seven people die. And for the first time in history, the world comes face to face with what would become one of the most dangerous viral families ever identified.

August 1967 — A City That Did Not See It Coming

Marburg an der Lahn is the kind of city that does not make international headlines. Founded in the 13th century, home to one of Germany's oldest universities — established in 1527 — it sits along a river surrounded by forested hills. In the summer of 1967, the most consequential thing happening in Marburg was not in the university's philosophy department or its chemistry laboratories. It was in the factory halls of Behringwerke AG — a pharmaceutical company producing, among other things, polio vaccines.

Polio had been one of the defining medical battles of the 20th century. The Salk vaccine, declared a triumph in 1955, required living cells for production — specifically, kidney cells from primates. African green monkeys (Cercopithecus aethiops) were the standard source. Tens of thousands had been imported from Africa to support vaccine production across Europe and North America. It was routine. It was essential. And in August 1967, a new shipment arrived from Uganda.

The monkeys were distributed to three facilities: Behringwerke in Marburg, the Paul Ehrlich Institute in Frankfurt, and a laboratory in Belgrade, Yugoslavia. Technicians followed standard protocol — anesthetizing the animals, removing the kidneys, preparing cell cultures. Then, one by one, the workers began to feel unwell. A sudden, high fever. Not gradual. Not mild. A fever that arrived within hours and did not break.

The Clinical Reality — What Was Actually Happening

The physicians who first encountered these patients were experienced clinicians. They considered bacterial infections, leptospirosis, typhoid. They administered antibiotics. Nothing worked. And then, between the third and fifth day after the fever began, the disease declared itself in a way that no one in European medicine had ever witnessed.

The hemorrhaging — the most dramatic and terrifying feature — is not caused by the virus directly destroying blood vessels. It is caused by something more insidious: the body's own immune response. Marburg virus targets macrophages and dendritic cells — the very immune cells that should be fighting it — and turns them into factories producing more virus. Simultaneously, it triggers a massive, dysregulated inflammatory response — a cytokine storm — that breaks down the barriers keeping blood contained within vessels throughout the body. It is, in a precise biological sense, the immune system attacking itself.

In total, 32 people were infected across the three cities — 25 from direct contact with the monkeys or their tissues, and 7 through secondary transmission from sick patients to healthcare workers and family members. Seven died. A case fatality rate of 23 percent. In a well-equipped European laboratory setting with trained physicians, this was devastating.

The Discovery — A New Virus, A New Family

The scientific response was immediate. Teams from the University of Marburg, the Bernhard Nocht Institute for Tropical Medicine in Hamburg, and collaborating virologists across Europe focused their electron microscopes on samples from infected patients. What they saw had never been described before. The virus particles were long and filamentous — thread-like structures, some straight, some curved into the shape of a shepherd's crook, others folded back on themselves into a U. Nothing in the virology literature matched this morphology.

They named it after the city where the majority of cases and deaths had occurred: the Marburg virus. And in doing so, they had inadvertently named the founding member of an entirely new viral family — the Filoviridae. A family whose second known member would be identified nine years later, in 1976, near a river in what is now the Democratic Republic of Congo. That second member would be called Ebola.

The Reservoir — Decades of Searching

The most important unanswered question after 1967 was: where had the virus come from? The monkeys were clearly the vehicle of human infection — but where had the monkeys acquired the virus? This question would remain partially open for decades. In 1980 and 1987, two isolated cases occurred in Kenya — both linked to visits to Kitum Cave on the slopes of Mount Elgon, a volcanic mountain near the Uganda-Kenya border. Both visitors died. The cave was investigated extensively, but the source could not be definitively identified at the time.

The answer finally came in 2007, when a team led by Jonathan Towner at the CDC isolated live Marburg virus from Egyptian fruit bats (Rousettus aegyptiacus) captured inside Kitum Cave and similar caves in Uganda. These animals carry the virus chronically — shedding it in saliva, urine, and feces — without ever becoming sick. They are the reservoir: the species in which Marburg virus maintains itself between human outbreaks, probably having done so for millions of years. The monkeys shipped to Germany in 1967 had almost certainly been exposed to bats or bat-contaminated environments in Uganda before capture. They were not the source of the virus. They were, like the human workers who opened their cages, accidental victims.

The Outbreaks That Followed

The Angola Outbreak — A Moment of Reckoning

The 2004–2005 outbreak in Uíge, Angola, deserves particular attention — because it remains the most devastating Marburg outbreak in history, and because the lessons it taught about community transmission, healthcare worker protection, and cultural responses to outbreak response remain relevant today.

The outbreak began in the pediatric ward of a hospital. Children were the first victims. Healthcare workers without adequate protective equipment became infected — and died — while caring for them. As news spread and fear grew, community members began hiding their sick relatives at home, avoiding the hospitals they associated with death. This decision, entirely understandable from the perspective of families watching loved ones die in clinical settings, paradoxically accelerated transmission within households. It took eight months, an enormous international response involving the WHO, MSF, and the CDC, and the painstaking work of local health authorities to eventually bring the outbreak to an end.

The Angola outbreak changed how the global health community thinks about filovirus response — particularly the imperative of community trust, transparent communication, and culturally appropriate engagement. Containment without community cooperation is impossible. The scientific tools mean nothing if the people most at risk do not understand or trust the people trying to help them.

What Changed — Biosafety Level 4 and the Science of Today

The immediate legacy of the 1967 Marburg outbreak was a fundamental transformation of laboratory biosafety. The technicians at Behringwerke who opened those cages without protection were not reckless — they simply did not know what they were dealing with. Nobody did. The virus had never been seen before. After 1967, the rules changed permanently. Biosafety Level 4 — the highest containment classification — was developed in direct response to viruses like Marburg and Ebola. Full protective suits. Negative-pressure rooms. Airlock entry systems. Chemical showers on exit. Complete containment of air, liquid, and solid waste. The requirement that researchers working with BSL-4 pathogens undergo extensive training, psychological screening, and buddy systems. All of this exists because of what happened in Marburg in 1967.

The Bottom Line

The Marburg virus did not begin in Germany. It began in the forests and caves of East Africa, in the bodies of bats that carry it silently across generations. But Germany is where it was discovered. Where it was named. Where the scientific framework for understanding an entire viral family was built from scratch — in the middle of a crisis, by researchers who had never seen anything like it and had no roadmap to follow.

Today, every person who works in a BSL-4 laboratory — with Ebola, with Marburg, with Nipah, with any of the world's most dangerous pathogens — works within a system of protection that was created because of what happened in Marburg in August 1967. The technicians who opened those cages paid a terrible price for knowledge that protects researchers everywhere today. Their story is not a story of failure. It is a story of how science learns — sometimes brutally, always permanently.